Orchid Pharma's new Antimicrobial Solutions division aims to achieve a turnover of Rs 300 crore in three years, tackling ...

Despite FDA restrictions, drugmakers, including Cephalon and later its parent company Teva pharmaceuticals, faced lawsuits for downplaying the drug's addiction risks and promoting the medication to ...

Universe Pharmaceuticals INC (the "Company," "we," "our" and "us") (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced ...

The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing ...

Creating a novel drug has always been a risky endeavor for biopharmaceutical companies. Developers and investors face ...

In the latest supply deal on the active pharmaceutical ingredients (API) front, Gilead Sciences has tapped South Korea’s ...

Mankind Pharma's strategic partnership with Bharat Serums and Vaccines poised for significant growth potential.

The medtech industry hopes to capitalise on increased awareness about the obesity space to promote multidisciplinary ...

Until recently, the pharmaceutical industry remained relatively insulated from the simmering trade war between China and the ...

PM sells Vectura Group to Molex Asia Holdings amid criticism of its ownership as it seeks to shift from tobacco to healthcare ...

Company is investing $2.8bn in two Irish plants to produce its in-demand weight loss drugs and a new Alzheimer’s therapy ...

Bausch Health is rumored to be looking to sell its Bausch + Lomb business, which will ease bankruptcy concerns and upgrade ...